Postoperative Vision Loss after Reverse Shoulder Arthroplasty

Case Reports in Orthopedics ◽

10.1155/2014/850950 ◽

2014 ◽

Vol 2014 ◽

pp. 1-5

Author(s):

Aadil Mumith ◽

John Scadden

Keyword(s):

Shoulder Arthroplasty ◽

Orthopaedic Surgery ◽

Vision Loss ◽

Reverse Shoulder Arthroplasty ◽

Curative Treatment ◽

Preventative Measures ◽

First Case ◽

Arthroplasty Surgery

We report a case which highlights the rare but devastating complication of postoperative vision loss (POVL) in orthopaedic surgery. Though documented previously, it has not been reported in shoulder arthroplasty surgery of which we present the first case. The aetiology of POVL is difficult to elucidate due to its elusive nature. We explain the risks associated with regional blocks used for such surgery and how this may be related to POVL. We must be vigilant of the possible causes of POVL as curative treatment is often not possible and hence must take preventative measures which we have recommended. Fortunately, the patient fully recovered at 10 months postoperatively with excellent function of her reverse shoulder arthroplasty.

Download Full-text

Utilization of Reverse Shoulder Arthroplasty for the Treatment of Glenohumeral Arthritis Among American Board of Orthopaedic Surgery (ABOS) Part II Candidates, 2008-2019

Seminars in Arthroplasty ◽

10.1053/j.sart.2021.06.005 ◽

2021 ◽

Author(s):

Olivia C. O'Reilly ◽

Molly A. Day ◽

Mary Kate Skalitzky ◽

Trevor R. Gulbrandsen ◽

Brendan M. Patterson

Keyword(s):

Shoulder Arthroplasty ◽

Orthopaedic Surgery ◽

Reverse Shoulder Arthroplasty ◽

Glenohumeral Arthritis

Download Full-text

Impact of intravenous tranexamic acid on patients undergoing shoulder arthroplasty surgery

Shoulder & Elbow ◽

10.1177/1758573220970907 ◽

2020 ◽

pp. 175857322097090

Author(s):

E Kissin ◽

K Al-Tawil ◽

A Tavakkolizadeh ◽

J Sinha ◽

T Colegate-Stone

Keyword(s):

Blood Loss ◽

Tranexamic Acid ◽

Shoulder Arthroplasty ◽

Reverse Shoulder Arthroplasty ◽

Total Shoulder Arthroplasty ◽

Transfusion Requirements ◽

Significant Difference ◽

Venous Thromboembolic Events ◽

Venous Thromboembolic ◽

Arthroplasty Surgery

Background Shoulder arthroplasty surgery carries the risk of blood loss. The antifibrinolytic tranexamic acid (TXA) is effective in reducing blood loss in lower limb arthroplasty. The purpose of this study was to assess blood loss and associated complications following shoulder arthroplasty performed with and without TXA for both elective and trauma indications. Methods A cohort study was performed to assess blood loss, transfusion requirements and post-operative venous thromboembolic events (VTE) following shoulder arthroplasty undertaken with and without the use of intravenous TXA. Results The study consisted of 67 patients ( n = 36 with TXA; n = 31 without TXA). Type of arthroplasty included reverse-shoulder arthroplasty, total-shoulder arthroplasty and hemiarthroplasty. There was no significant difference between TXA and non-TXA groups regarding blood loss (TXA group haemoglobin drop 20.6 mg/dL; non-TXA group haemoglobin drop 20.5 mg/dL; p = 0.978). There was no significant difference in measured outcomes with or without TXA use for elective or trauma indications, nor regarding type of arthroplasty. Discussion The use of intravenous TXA in shoulder arthroplasty was not associated with a significant reduction in blood loss or post-operative transfusion rates, nor did it impact on VTE. This result was not affected by the indication being elective or trauma nor the type of arthroplasty surgery performed.

Download Full-text